Clinica Baviera (STU:D9Z) Cyclically Adjusted FCF per Share: € (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:D9Z Clinica Baviera SA STU:D9Z
100 GF Score
Price €56.60
GF Value €44.80
! 5 Warning Signs
View Full Analysis

What is Clinica Baviera Cyclically Adjusted FCF per Share?

Clinica Baviera STU:D9Z -0.35% 100 Cyclically Adjusted FCF per Share is € as of Jun. 2026. GuruFocus rates STU:D9Z with a GF Score™ of 100/100 and a GF Value™ of €44.80. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Clinica Baviera's adjusted free cash flow per share for the three months ended in Jun. 2026 was €0.771. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, Clinica Baviera's average Cyclically Adjusted FCF Growth Rate was 7.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 13.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Clinica Baviera was 27.20% per year. The lowest was 7.00% per year. And the median was 14.95% per year.

As of today (2026-09-21), Clinica Baviera's current stock price is €56.60. Clinica Baviera's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was . Clinica Baviera's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Clinica Baviera was 26.47. The lowest was 7.92. And the median was 14.07.


Clinica Baviera  (STU:D9Z) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Clinica Baviera was 26.47. The lowest was 7.92. And the median was 14.07.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Clinica Baviera Cyclically Adjusted FCF per Share Related Terms


Clinica Baviera Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Clinica Baviera's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica Baviera Cyclically Adjusted FCF per Share Chart

Clinica Baviera Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Clinica Baviera Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STU:D9Z vs TMO, DHR, NTRA: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, Clinica Baviera's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clinica Baviera Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clinica Baviera's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Clinica Baviera's Cyclically Adjusted Price-to-FCF falls into.


STU:D9Z
100GF Score
Clinica Baviera SA STU:D9Z
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clinica Baviera Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Clinica Baviera's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.771/131.3300*131.3300
=0.771

Current CPI (Jun. 2026) = 131.3300.

Clinica Baviera Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201112 0.000 98.235 0.000
201203 0.000 97.909 0.000
201206 0.000 98.952 0.000
201209 0.000 100.254 0.000
201212 0.000 101.052 0.000
201303 0.000 100.284 0.000
201306 0.000 100.994 0.000
201309 0.000 100.597 0.000
201312 0.000 101.306 0.000
201403 0.000 100.139 0.000
201409 0.000 100.441 0.000
201503 0.000 99.474 0.000
201509 0.043 99.559 0.057
201603 0.000 98.638 0.000
202003 0.241 103.469 0.306
202006 0.179 104.254 0.225
202009 0.583 103.521 0.740
202012 0.439 104.456 0.552
202103 0.558 104.857 0.699
202106 0.718 107.102 0.880
202109 0.428 107.669 0.522
202112 0.042 111.298 0.050
202203 0.906 115.153 1.033
202206 0.610 118.044 0.679
202209 0.375 117.221 0.420
202212 0.499 117.650 0.557
202303 0.841 118.948 0.929
202306 0.457 120.278 0.499
202309 0.404 121.343 0.437
202312 0.455 121.300 0.493
202403 0.828 122.762 0.886
202406 0.692 124.409 0.730
202409 0.271 123.121 0.289
202412 0.446 124.753 0.470
202503 1.196 125.531 1.251
202506 0.736 127.251 0.760
202509 0.530 126.840 0.549
202512 0.516 128.400 0.528
202603 1.106 129.860 1.119
202606 0.771 131.330 0.771

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of € mean?
Clinica Baviera (STU:D9Z) has a Cyclically Adjusted FCF per Share of € as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Clinica Baviera and its competitors.
Is Clinica Baviera's Cyclically Adjusted FCF per Share too high?
Clinica Baviera's current Cyclically Adjusted FCF per Share is €. Overall, Clinica Baviera has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Clinica Baviera's Cyclically Adjusted FCF per Share compare to TMO and DHR?
Clinica Baviera's Cyclically Adjusted FCF per Share of € can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Clinica Baviera and its competitors. Clinica Baviera's current Cyclically Adjusted FCF per Share is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica Baviera stock overvalued right now?
Clinica Baviera (STU:D9Z) has a current Cyclically Adjusted FCF per Share of €. The stock's GF Value™ is €44.80, compared to a current price of €56.60 — trading 26.3% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €. Clinica Baviera's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Clinica Baviera (STU:D9Z), the current Cyclically Adjusted FCF per Share is € as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clinica Baviera (STU:D9Z) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €56.60 is trading 26.3% above its estimated GF Value™ of €44.80.

Key valuation signals for STU:D9Z:

  • Cyclically Adjusted FCF per Share:
  • GF Value™: €44.80 vs. price of €56.60 (26.3% above fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the STU:D9Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinica Baviera Business Description

Other Exchanges 0GWJ:UKCBAV:Spain
Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
100GF Score

Get the complete analysis for STU:D9Z

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€56.60
Price
€44.80
GF Value